Total Funding
87
82
Total FundingSeries B raised
Growth Score 87 in past quarter
-1 pts
Heat Score 82 in past quarter
11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
99867
Neuroventi develops and provides customizes solutions and treatments for brain development disorders.
- Shin Chan-young: CEO
- Dong-Churl Seo: CEO
About the Company
Neuroventi is a biotechnology venture that focuses on creating therapies for neurological disorders. It is engaged in the development of small molecule medications targeting neurodevelopmental disorders such as autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), and depression, while also performing preclinical contract
development and research organization (CDRO).